InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

SS

Sangha, Steven

OWNER 10PCT

BetterLife Pharma Inc.Sernova Biotherapeutics Inc.

Cumul. flow

0

Total declarations

0

Companies

€37,203

▲ Purchases (9 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

9

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the complete record of transactions filed by Sangha, Steven. Officer active across 2 companies, notably BetterLife Pharma Inc.. In total, 13 disclosures have been logged. Split: 9 buys · 0 sell. Total volume traded: €37k. Activity tracked since 26 May 2026. The latest transaction was disclosed on 19 June 2026 (52 - Expiration of options). Regulator: SEDI. All data is openly available.

Declarations13 total

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives22 Jun 2026BetterLife Pharma Inc.

@ €0.0369Convertible DebenturesTSXSEDI:4738529

Ideal exit: 19 Mar 2027 (T+270)

●

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives5 Jan 2024BetterLife Pharma Inc.

Convertible DebenturesTSXSEDI:4738528

◇

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives19 Jun 2026BetterLife Pharma Inc.

CA$15,00028SEDI ↗

200,000 shares@ CA$0.0750.17% mcap7.3% of flowOptionsTSXSEDI:4737728

●

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives13 Jun 2026BetterLife Pharma Inc.

CA$130,00039SEDI ↗

1,000,000 shares@ CA$0.131.38% mcap68.4% of flowWarrantsTSXSEDI:4736627

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives5 Jun 2026BetterLife Pharma Inc.

CA$3,12027SEDI ↗

52,000 shares@ CA$0.060.038% mcap5.2% of flowCommon SharesTSXSEDI:4730181

Ideal exit: 2 Mar 2027 (T+270)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives4 Jun 2026BetterLife Pharma Inc.

CA$13,74032SEDI ↗

229,000 shares@ CA$0.060.17% mcap24.1% of flowCommon SharesTSXSEDI:4728878

Ideal exit: 1 Mar 2027 (T+270)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives1 Jun 2026BetterLife Pharma Inc.

CA$7,26023SEDI ↗

121,000 shares@ CA$0.0616.9% of flowCommon SharesTSXSEDI:4726533

Ideal exit: 26 Feb 2027 (T+270)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives29 May 2026BetterLife Pharma Inc.

CA$7,56023SEDI ↗

126,000 shares@ CA$0.0621.1% of flowCommon SharesTSXSEDI:4725431

Ideal exit: 23 Feb 2027 (T+270)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives28 May 2026BetterLife Pharma Inc.

CA$7,62024SEDI ↗

127,000 shares@ CA$0.0627.0% of flowCommon SharesTSXSEDI:4724932

Ideal exit: 22 Feb 2027 (T+270)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives27 May 2026BetterLife Pharma Inc.

CA$12017SEDI ↗

2,000 shares@ CA$0.060.4% of flowCommon SharesTSXSEDI:4724931

Ideal exit: 21 Feb 2027 (T+270)

◇

4 - Director of IssuerExecutives22 May 2026Sernova Biotherapeutics Inc.

CA$41,60019SEDI ↗

260,000 shares@ CA$0.16100.0% of flowOptionsTSXSEDI:4724422

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives27 May 2026BetterLife Pharma Inc.

CA$19,62025SEDI ↗

327,000 shares@ CA$0.0695.6% of flowCommon SharesTSXSEDI:4724251

Ideal exit: 21 Feb 2027 (T+270)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives26 May 2026BetterLife Pharma Inc.

CA$90023SEDI ↗

15,000 shares@ CA$0.06100.0% of flowCommon SharesTSXSEDI:4724035

Ideal exit: 20 Feb 2027 (T+270)

13 of 13 declarations

About Sangha, Steven

Steven Sangha is a declarant associated with BetterLife Pharma Inc., where he is 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, and with Sernova Biotherapeutics Inc., where he is 4 - Director of Issuer. The 13 filings in total include, for the sampled recent filings from 2026-05-26 to 2026-06-22, buys of EUR 37203 and no sells.